Skip to main content
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: Human laboratory findings
- Author(s): Ray, LA
- Courtney, KE
- Ghahremani, DG
- Miotto, K
- Brody, A
- London, ED
- et al.
Published Web Locationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161630/
No data is associated with this publication.
Rationale: Heavy-drinking smokers constitute a sizeable and hard-to-treat subgroup of smokers, for whom tailored smoking cessation therapies are not yet available.
Item not freely available? Link broken?Report a problem accessing this item